Last reviewed · How we verify
Glucocorticoid
At a glance
| Generic name | Glucocorticoid |
|---|---|
| Also known as | Hydrocortisone, dexamethasone, prednisone, methylprednisolone, Prednisone, Hydrocortisone |
| Sponsor | Southeast University, China |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement (NA)
- Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction (PHASE2)
- Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome (NA)
- A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China (PHASE4)
- Polycystic Ovary Syndrome in Type 1 Diabetes
- A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head (PHASE2)
- Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder (EARLY_PHASE1)
- Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glucocorticoid CI brief — competitive landscape report
- Glucocorticoid updates RSS · CI watch RSS
- Southeast University, China portfolio CI